Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note - PubMed (original) (raw)
. 1989 Nov 1;49(21):5870-8.
Affiliations
- PMID: 2790800
Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note
S H Kaufmann. Cancer Res. 1989.
Abstract
Treatment of human HL-60 or KG1A leukemia cells with the topoisomerase II inhibitor etoposide resulted in extensive DNA degradation. When DNA integrity was analyzed by agarose gel electrophoresis, a nucleosomal ladder became evident 1.5-2 h after addition of etoposide to cells, increased in intensity over 6 h, and persisted at 24 h. Six h after addition of the drug, 94 +/- 4% of the cells excluded trypan blue even though as much as 90% of the DNA had been degraded to oligosomal fragments. Exposure of cells to 10 micrograms/ml (17 microM) etoposide for as little as 45 min was sufficient to induce this DNA damage 4 h later. Preincubation with dinitrophenol abolished the effect of etoposide, suggesting that an energy-requiring step occurred prior to or during the endonucleolytic cleavage. In contrast, the effect of etoposide was not prevented by preincubation of HL-60 cells with the RNA synthesis inhibitor 5,6-dichloro-1-beta-ribofuranosylbenzimidazole or the protein synthesis inhibitors cycloheximide or puromycin. On the contrary, high concentrations of 5,6-dichloro-1-beta-ribofuranosylbenzimidazole, cycloheximide, or puromycin by themselves induced the same endonucleolytic cleavage, as did a variety of diverse cytotoxic agents, including camptothecin (0.1 microM), colcemid (0.1 microgram/ml), cis-platinum (20 microM), methotrexate (1 microM), and 1-beta-D-arabinofuranosylcytosine (3 microM). These results suggest that endonucleolytic DNA damage by a preexisting cellular enzyme occurs soon after treatment of HL-60 cells with any of a variety of cytotoxic agents. The observation that a variety of nuclear proteins [including poly(ADP-ribose) polymerase, lamin B, topoisomerase I, topoisomerase II, and histone H1] are degraded concomitant with the DNA fragmentation calls into question the selectivity of the degradative process for DNA. The implications of these results for (a) current theories which focus upon endonucleolytic damage of DNA as a critical early event during cell death, and (b) use of topoisomerase-directed drugs to map topoisomerase-binding sites in active chromatin are discussed.
Similar articles
- Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Kaufmann SH, et al. Cancer Res. 1993 Sep 1;53(17):3976-85. Cancer Res. 1993. PMID: 8358726 - Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y. Bertrand R, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6280-5. Cancer Res. 1991. PMID: 1933888 - [The mechanism of apoptosis induced by anticancer agents in human leukemia cells].
Yoshida A, Ueda T. Yoshida A, et al. Nihon Rinsho. 1996 Jul;54(7):1822-7. Nihon Rinsho. 1996. PMID: 8741673 Review. Japanese. - [DNA damage and anticancer effect].
Kanamaru R, Ishioka C, Konishi Y, Ishikawa S, Shibata H, Wakui A. Kanamaru R, et al. Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):517-23. Gan To Kagaku Ryoho. 1990. PMID: 2181939 Review. Japanese.
Cited by
- Unravelling oncosis: morphological and molecular insights into a unique cell death pathway.
Guo J, Yang WT, Mai FY, Liang JR, Luo J, Zhou MC, Yu DD, Wang YL, Li CG. Guo J, et al. Front Immunol. 2024 Aug 29;15:1450998. doi: 10.3389/fimmu.2024.1450998. eCollection 2024. Front Immunol. 2024. PMID: 39281670 Free PMC article. Review. - Endophytic fungi: A future prospect for breast cancer therapeutics and drug development.
Varghese S, Jisha MS, Rajeshkumar KC, Gajbhiye V, Alrefaei AF, Jeewon R. Varghese S, et al. Heliyon. 2024 Jul 4;10(13):e33995. doi: 10.1016/j.heliyon.2024.e33995. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39091955 Free PMC article. Review. - Actinomycin D and bortezomib disrupt protein homeostasis in Wilms tumor.
Tiburcio PDB, Chen K, Xu L, Chen KS. Tiburcio PDB, et al. bioRxiv [Preprint]. 2024 Jun 20:2024.06.11.598518. doi: 10.1101/2024.06.11.598518. bioRxiv. 2024. PMID: 38948702 Free PMC article. Preprint. - Surveying the landscape of emerging and understudied cell death mechanisms.
Leak L, Dixon SJ. Leak L, et al. Biochim Biophys Acta Mol Cell Res. 2023 Mar;1870(3):119432. doi: 10.1016/j.bbamcr.2023.119432. Epub 2023 Jan 21. Biochim Biophys Acta Mol Cell Res. 2023. PMID: 36690038 Free PMC article. Review. - Screening of ferrocenyl-phosphines identifies a gold-coordinated derivative as a novel anticancer agent for hematological malignancies.
Verma NK, Sadeer A, Kizhakeyil A, Pang JH, Angela Chiu QY, Tay SW, Kumar P, Pullarkat SA. Verma NK, et al. RSC Adv. 2018 Aug 14;8(51):28960-28968. doi: 10.1039/c8ra05224g. eCollection 2018 Aug 14. RSC Adv. 2018. PMID: 35547965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources